4.5 Article

Long-term cardiac surveillance and outcomes of COVID-19 patients

Related references

Note: Only part of the references are listed.
Article Cardiac & Cardiovascular Systems

Clinically Suspected Myocarditis Temporally Related to COVID-19 Vaccination in Adolescents and Young Adults: Suspected Myocarditis After COVID-19 Vaccination

Dongngan T. Truong et al.

Summary: This study retrospectively analyzed the clinical characteristics and short-term outcomes of young individuals with suspected myocarditis after COVID-19 vaccination. The results showed that most cases of suspected myocarditis had a mild clinical course with rapid resolution of symptoms, and abnormal findings on cardiac MRI were frequent.

CIRCULATION (2022)

Article Cardiac & Cardiovascular Systems

Implantation of cardiac electronic devices in active COVID-19 patients: Results from an international survey

Oholi Tovia-Brodie et al.

Summary: The rates and outcomes of CIED procedures vary greatly in patients with known active COVID-19. Older patients in North America had higher rates of complications and mortality compared to Europe.

HEART RHYTHM (2022)

Article Biochemistry & Molecular Biology

Long-term cardiovascular outcomes of COVID-19

Yan Xie et al.

Summary: Individuals with COVID-19, even those who were not hospitalized during the acute phase of the infection, are at an increased long-term risk of various cardiovascular disorders. A study using national healthcare databases found that beyond the first 30 days after infection, individuals with COVID-19 have an elevated risk of developing cerebrovascular disorders, heart diseases, and other cardiovascular complications. The risk increases depending on the care setting during the acute phase.

NATURE MEDICINE (2022)

Article Biochemistry & Molecular Biology

Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection

Martina Patone et al.

Summary: The study found that there is an increased risk of myocarditis associated with the first dose of ChAdOx1 and BNT162b2 vaccines, as well as the first and second doses of the mRNA-1273 vaccine in the 1-28 days post-vaccination period. Additionally, individuals with SARS-CoV-2 infection also face a greater risk of myocarditis, pericarditis, and cardiac arrhythmia.

NATURE MEDICINE (2022)

Article Virology

Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation

Stephen J. Halpin et al.

Summary: This study is the first report from the United Kingdom on post-discharge symptoms in COVID-19 survivors, identifying fatigue, breathlessness, and psychological distress as common symptoms that require planning of rehabilitation services for appropriate management.

JOURNAL OF MEDICAL VIROLOGY (2021)

Article Infectious Diseases

Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study

Qiutang Xiong et al.

Summary: The study described the common clinical sequelae in COVID-19 survivors discharged from the hospital for more than 3 months, including general symptoms, respiratory symptoms, cardiovascular-related symptoms, psychosocial symptoms, and alopecia. Female patients were more likely to experience physical decline/fatigue, postactivity polypnoea, and alopecia.

CLINICAL MICROBIOLOGY AND INFECTION (2021)

Article Infectious Diseases

Follow-up of adults with noncritical COVID-19 two months after symptom onset

Claudia Carvalho-Schneider et al.

Summary: In noncritical COVID-19 patients, most individuals continued to experience symptoms up to 2 months after symptom onset, with the main complaints being anosmia/ageusia, dyspnoea, or asthenia. Factors associated with persistent symptoms included age 40-60 years old, hospital admission, and abnormal auscultation at symptom onset.

CLINICAL MICROBIOLOGY AND INFECTION (2021)

Review Cardiac & Cardiovascular Systems

Myocarditis and inflammatory cardiomyopathy: current evidence and future directions

Carsten Tschoepe et al.

Summary: Inflammatory cardiomyopathy is a disease characterized by inflammatory cell infiltration into the myocardium and is predominantly mediated by viral infection. Despite extensive research, inflammatory cardiomyopathy complicated by left ventricular dysfunction, heart failure or arrhythmia is associated with a poor prognosis. The relative roles of the pathogen, host genomics and environmental factors in disease progression and healing are still under discussion.

NATURE REVIEWS CARDIOLOGY (2021)

Review Cardiac & Cardiovascular Systems

Coronavirus Disease 2019 and the Athletic Heart Emerging Perspectives on Pathology, Risks, and Return to Play

Jonathan H. Kim et al.

Summary: This study addresses the impact of COVID-19 infection on cardiac pathology among patients, particularly in athletes. Despite lacking definitive data, it suggests a conservative return-to-play approach and cardiac risk assessment for athletes following COVID-19 recovery.

JAMA CARDIOLOGY (2021)

Letter Cardiac & Cardiovascular Systems

COVID-19 Myocardial Pathology Evaluation in Athletes With Cardiac Magnetic Resonance (COMPETE CMR)

Daniel E. Clark et al.

CIRCULATION (2021)

Article Cardiac & Cardiovascular Systems

Microthrombi as a Major Cause of Cardiac Injury in COVID-19 A Pathologic Study

Dario Pellegrini et al.

Summary: Analysis of heart tissue from 40 deceased COVID-19 patients revealed that microthrombi were the most common pathological cause of myocyte necrosis. Female patients with chronic kidney disease and shorter symptom onset to admission time were more likely to have myocyte necrosis. Tailored antithrombotic strategies may be useful to counteract the cardiac effects of COVID-19 infection.

CIRCULATION (2021)

Article Respiratory System

Cardiopulmonary recovery after COVID-19: an observational prospective multicentre trial

Thomas Sonnweber et al.

Summary: A study found that some COVID-19 patients still experienced persistent symptoms and lung function impairment 100 days after the onset of the disease, but there was significant improvement in symptoms and cardiopulmonary status over time.

EUROPEAN RESPIRATORY JOURNAL (2021)

Review Medicine, General & Internal

Myocarditis in COVID-19 patients: current problems

Donato Mele et al.

Summary: This brief review aims to summarize the current knowledge on myocarditis in COVID-19 patients and highlight issues related to diagnosis and treatment. There is a lack of information on the mechanisms, prevalence, prognosis, diagnosis, and therapy of myocarditis in the context of COVID-19.

INTERNAL AND EMERGENCY MEDICINE (2021)

Article Cardiac & Cardiovascular Systems

Use of the new Lake Louise Criteria improves CMR detection of atypical forms of acute myocarditis

Giulia Cundari et al.

Summary: This study compared the diagnostic performance of old and new Lake Louise Criteria for acute myocarditis among different clinical presentations. The results showed that the new criteria had improved diagnostic performance for acute myocarditis, particularly in atypical clinical presentations.

INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Cardiac involvement in consecutive elite athletes recovered from Covid-19: A magnetic resonance study

Lukasz A. Malek et al.

Summary: Studies using magnetic resonance imaging have shown that a subset of elite athletes affected by Covid-19, mainly asymptomatic or with mild symptoms, did not exhibit signs of acute myocarditis, but 19% of athletes showed cardiac abnormalities on MRI.

JOURNAL OF MAGNETIC RESONANCE IMAGING (2021)

Article Medicine, General & Internal

6-month consequences of COVID-19 in patients discharged from hospital: a cohort study (Publication with Expression of Concern. See vol. 401, pg. 90, 2023)

Chaolin Huang et al.

Summary: This study aimed to investigate the long-term health consequences of discharged COVID-19 patients and associated risk factors, particularly disease severity. Patients with more severe illness during hospitalization showed more severe impaired pulmonary diffusion capacities and abnormal chest imaging manifestations, highlighting the need for targeted interventions for long-term recovery.

LANCET (2021)

Article Cardiac & Cardiovascular Systems

Viral myocarditis: 1917?2020: From the Influenza A to the COVID-19 pandemics * , ** , ?

Shereif H. Rezkalla et al.

Summary: Myocarditis is common in viral infections, with elevated troponin in 36% of COVID patients. Diagnostic tools include ECG, echocardiogram, and cardiac MRI. Cardiac inflammation can result from viral invasion or cytokine storm.

TRENDS IN CARDIOVASCULAR MEDICINE (2021)

Article Cardiac & Cardiovascular Systems

Management of STEMI during the COVID-19 pandemic: Lessons learned in 2020 to prepare for 2021*, **

Vardhmaan Jain et al.

Summary: During the COVID-19 pandemic, challenges in managing STEMI have emerged due to social distancing measures and restricted access to healthcare services, potentially leading to delayed treatment and worse outcomes for patients. Solutions for adhering to evidence-based therapies are discussed as the pandemic progresses into 2021.

TRENDS IN CARDIOVASCULAR MEDICINE (2021)

Article Immunology

Myopericarditis after vaccination, Vaccine Adverse Event Reporting System (VAERS), 1990-2018

John R. Su et al.

Summary: A thorough analysis of myopericarditis reports to a national vaccine safety surveillance system in the United States revealed that most cases involved males with symptoms occurring within two weeks post-vaccination. Smallpox and anthrax vaccines were the most commonly reported vaccines associated with myopericarditis.

VACCINE (2021)

Letter Cardiac & Cardiovascular Systems

Cardiac Magnetic Resonance Findings in Patients Recovered From COVID-19 Initial Experiences in Elite Athletes

Hajnalka Vago et al.

JACC-CARDIOVASCULAR IMAGING (2021)

Review Cardiac & Cardiovascular Systems

Exercise-Induced Cardiovascular Adaptations and Approach to Exercise and Cardiovascular Disease JACC State-of-the-Art Review

Matthew W. Martinez et al.

Summary: The role of sports cardiologists is essential in the medical care of athletes, focusing on distinguishing between physiological adaptations and pathological changes, and providing risk assessment for sports participation.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)

Article Cardiac & Cardiovascular Systems

Worldwide Survey of COVID-19-Associated Arrhythmias

Ellie J. Coromilas et al.

Summary: COVID-19 patients with cardiac complications, particularly cardiac arrhythmias, have high morbidity and mortality. The study revealed common cardiac comorbidities among patients with arrhythmias and most had no prior history of arrhythmia. Regional variations were observed in the types of arrhythmias and treatment approaches.

CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2021)

Article Cardiac & Cardiovascular Systems

High Prevalence of Pericardial Involvement in College Student Athletes Recovering From COVID-19

Daniel Brito et al.

Summary: This study aimed to explore the spectrum of cardiac abnormalities in student athletes who returned to university campus in July 2020 with uncomplicated COVID-19. It was found that more than one in three previously healthy college athletes recovering from COVID-19 showed imaging features of resolving pericardial inflammation, with no specific imaging features of ongoing myocarditis identified. Further studies are needed to understand the clinical implications and long-term evolution of these abnormalities in uncomplicated COVID-19.

JACC-CARDIOVASCULAR IMAGING (2021)

Article Cardiac & Cardiovascular Systems

Prevalence of Inflammatory Heart Disease Among Professional Athletes With Prior COVID-19 Infection Who Received Systematic Return-to-Play Cardiac Screening

Matthew W. Martinez et al.

Summary: This study assessed the prevalence of relevant COVID-19-associated cardiac pathology in professional athletes and found few cases of inflammatory heart disease. Most athletes were able to safely return to professional sports activities after cardiac screening.

JAMA CARDIOLOGY (2021)

Letter Medicine, General & Internal

Sixty-Day Outcomes Among Patients Hospitalized With COVID-19

Vineet Chopra et al.

ANNALS OF INTERNAL MEDICINE (2021)

Article Cardiac & Cardiovascular Systems

SARS-CoV-2 Cardiac Involvement in Young Competitive Athletes

Nathaniel Moulson et al.

Summary: This study investigated the prevalence and clinical implications of COVID-19 cardiac involvement in young competitive athletes in the United States. The results showed a low prevalence of cardiac involvement and a low risk of clinical events in short-term follow-up among these athletes.

CIRCULATION (2021)

Article Multidisciplinary Sciences

High-dimensional characterization of post-acute sequelae of COVID-19

Ziyad Al-Aly et al.

Summary: This study comprehensively describes the post-acute sequelae of COVID-19 using national healthcare databases, finding increased risk of death and use of health resources beyond the first 30 days of illness, as well as incident sequelae in various organ systems, increased use of therapeutic agents, and evidence of laboratory abnormalities. The findings show a risk gradient according to the severity of acute COVID-19 infection and highlight the burden of health loss experienced by patients who survive the acute phase.

NATURE (2021)

Article Cardiac & Cardiovascular Systems

Prospective Case-Control Study of Cardiovascular Abnormalities 6 Months Following Mild COVID-19 in Healthcare Workers

George Joy et al.

Summary: This study found that there was no significant difference in the occurrence of cardiovascular abnormalities between seropositive and seronegative healthy healthcare workers 6 months after mild COVID-19 infection.

JACC-CARDIOVASCULAR IMAGING (2021)

Article Cardiac & Cardiovascular Systems

Cardiac performance in patients hospitalized with COVID-19: a 6 month follow-up study

Antoine Fayol et al.

Summary: Significant cardiac diastolic abnormalities are observed in patients who experienced myocardial injury six months after the acute COVID-19 phase, but not in patients without cardiac involvement.

ESC HEART FAILURE (2021)

Article Medicine, General & Internal

Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting

Noam Barda et al.

Summary: The study found that after receiving the BNT162b2 vaccine, most adverse events were not associated with an increased risk, although there was a slight increase in the risk of myocarditis. On the other hand, infection with the Covid-19 virus significantly increased the risk of many serious adverse events.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Public, Environmental & Occupational Health

Association Between COVID-19 and Myocarditis Using Hospital-Based Administrative Data — United States, March 2020–January 2021

Tegan K. Boehmer et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)

Article Cardiac & Cardiovascular Systems

Prevalence of Clinical and Subclinical Myocarditis in Competitive Athletes With Recent SARS-CoV-2 Infection Results From the Big Ten COVID-19 Cardiac Registry

Curt J. Daniels et al.

Summary: In this study of 1597 competitive athletes in the US who underwent CMR screening after COVID-19 infection, 37 athletes (2.3%) were diagnosed with clinical and subclinical myocarditis. There was variability in prevalence across universities, and testing protocols were closely associated with the detection of myocarditis. The unique CMR imaging data highlight the need for standardized timing and interpretation of cardiac testing for safe return to play in athletes.

JAMA CARDIOLOGY (2021)

Article Medicine, General & Internal

Characterizing long COVID in an international cohort: 7 months of symptoms and their impact

Hannah E. Davis et al.

Summary: Patients with Long COVID report prolonged, multisystem involvement and significant disability. By seven months, many patients have not yet recovered (mainly from systemic and neurological/cognitive symptoms), have not returned to previous levels of work, and continue to experience significant symptom burden.

ECLINICALMEDICINE (2021)

Review Cardiac & Cardiovascular Systems

Systematic Review of COVID-19 Related Myocarditis: Insights on Management and Outcome

Khalid Sawalha et al.

Summary: COVID-19 infection can lead to myocarditis, with a male predominance and a median age of 50.4 years in reported cases. While most patients did not have previously identified comorbid conditions, hypertension was the most prevalent. Elevated troponin levels were common, and echocardiography revealed reduced function in 60% of cases. Most patients survived to discharge, with a high percentage of those receiving steroids also surviving. Treatment approaches for COVID-19 myocarditis are still evolving and should be individualized until more research is conducted.

CARDIOVASCULAR REVASCULARIZATION MEDICINE (2021)

Article Medicine, General & Internal

Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study

Andrea Dennis et al.

Summary: A study conducted in two UK community centers found that 70% of individuals with persistent symptoms following recovery from SARS-CoV-2 infection had impairment in one or more organs 4 months after initial COVID-19 symptoms. Common symptoms included fatigue, muscle aches, breathlessness, and headaches.

BMJ OPEN (2021)

Article Cardiac & Cardiovascular Systems

Cardiac Involvement in Patients Recovered From COVID-2019 Identified Using Magnetic Resonance Imaging

Lu Huang et al.

JACC-CARDIOVASCULAR IMAGING (2020)

Article Cardiac & Cardiovascular Systems

Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)

Tao Guo et al.

JAMA CARDIOLOGY (2020)

Article Cardiac & Cardiovascular Systems

Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China

Shaobo Shi et al.

JAMA CARDIOLOGY (2020)

Review Cardiac & Cardiovascular Systems

COVID-19 cardiac injury: Implications for long-term surveillance and outcomes in survivors

Raul D. Mitrani et al.

HEART RHYTHM (2020)

Review Medicine, General & Internal

Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19) A Review

W. Joost Wiersinga et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Letter Medicine, General & Internal

Persistent Symptoms in Patients After Acute COVID-19

Angelo Carfi et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Article Cardiac & Cardiovascular Systems

COVID-19 and cardiac arrhythmias: a global perspective on arrhythmia characteristics and management strategies

Rakesh Gopinathannair et al.

JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY (2020)

Review Biochemistry & Molecular Biology

Extrapulmonary manifestations of COVID-19

Aakriti Gupta et al.

NATURE MEDICINE (2020)

Letter Cardiac & Cardiovascular Systems

Arrhythmic Complications of Patients Hospitalized With COVID-19 Incidence, Risk Factors, and Outcomes

Bradley Peltzer et al.

CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2020)

Article Cardiac & Cardiovascular Systems

Bradyarrhythmias in patients with COVID-19: Marker of poor prognosis?

Jason S. Chinitz et al.

PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY (2020)

Article Cardiac & Cardiovascular Systems

COVID-19 infection and cardiac arrhythmias

Antonis S. Manolis et al.

TRENDS IN CARDIOVASCULAR MEDICINE (2020)

Review Cardiac & Cardiovascular Systems

Screening of Potential Cardiac Involvement in Competitive Athletes Recovering From COVID-19

Dermot Phelan et al.

JACC-CARDIOVASCULAR IMAGING (2020)

Article Cardiac & Cardiovascular Systems

Prevalence and pattern of cardiovascular magnetic resonance late gadolinium enhancement in highly trained endurance athletes

B. Domenech-Ximenos et al.

JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE (2020)

Article Cardiac & Cardiovascular Systems

Coronary and cerebral thrombosis in a young patient after mild COVID-19 illness: a case report

Lauren S. Ranard et al.

EUROPEAN HEART JOURNAL-CASE REPORTS (2020)

Article Cardiac & Cardiovascular Systems

Prognostic Value of Repeating Cardiac Magnetic Resonance in Patients With Acute Myocarditis

Giovanni Donato Aquaro et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)

Article Cardiac & Cardiovascular Systems

Prospective Countywide Surveillance and Autopsy Characterization of Sudden Cardiac Death POST SCD Study

Zian H. Tseng et al.

CIRCULATION (2018)

Article Cardiac & Cardiovascular Systems

Inflammatory Cardiomyopathic Syndromes

Barry H. Trachtenberg et al.

CIRCULATION RESEARCH (2017)

Article Medicine, General & Internal

Acute myocarditis associated with novel Middle East respiratory syndrome coronavirus

Tariq Alhogbani

ANNALS OF SAUDI MEDICINE (2016)

Article Cardiac & Cardiovascular Systems

Ventricular myocarditis coincides with atrial myocarditis in patients

Mark P. V. Begieneman et al.

CARDIOVASCULAR PATHOLOGY (2016)

Article Cardiac & Cardiovascular Systems

Native T1 and T2 mapping by CMR in lupus myocarditis: Disease recognition and response to treatment

Rocio Hinojar et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)

Article Cardiac & Cardiovascular Systems

Seasonal Influenza Infections and Cardiovascular Disease Mortality

Jennifer L. Nguyen et al.

JAMA CARDIOLOGY (2016)

Article Cardiac & Cardiovascular Systems

Long-Term Evolution and Prognostic Stratification of Biopsy-Proven Active Myocarditis

Marco Anzini et al.

CIRCULATION (2013)

Article Cardiac & Cardiovascular Systems

Long-Term Follow-Up of Biopsy-Proven Viral Myocarditis Predictors of Mortality and Incomplete Recovery

Stefan Gruen et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)

Article Cardiac & Cardiovascular Systems

Diagnostic Performance of CMR Imaging Compared With EMB in Patients With Suspected Myocarditis

Philipp Lurz et al.

JACC-CARDIOVASCULAR IMAGING (2012)

Article Cardiac & Cardiovascular Systems

Sudden Deaths in Young Competitive Athletes Analysis of 1866 Deaths in the United States, 1980-2006

Barry J. Maron et al.

CIRCULATION (2009)

Article Medicine, General & Internal

SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS

G. Y. Oudit et al.

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2009)

Article Cardiac & Cardiovascular Systems

Usefulness of Immunosuppression for Giant Cell Myocarditis

Leslie T. Cooper et al.

AMERICAN JOURNAL OF CARDIOLOGY (2008)

Review Cardiac & Cardiovascular Systems

Postmortem diagnosis in sudden cardiac death victims: macroscopic, microscopic and molecular findings

C Basso et al.

CARDIOVASCULAR RESEARCH (2001)

Article Medicine, General & Internal

Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis.

RE McCarthy et al.

NEW ENGLAND JOURNAL OF MEDICINE (2000)